Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies.

Saved in:
Bibliographic Details
Title: Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies.
Authors: Ferrari M; Autolus Therapeutics, London, UK., Righi M; Autolus Therapeutics, London, UK., Baldan V; Autolus Therapeutics, London, UK., Wawrzyniecka P; Cardiff University School of Medicine; Heath Park, Cardiff, UK., Bulek A; Autolus Therapeutics, London, UK., Kinna A; Autolus Therapeutics, London, UK., Ma B; Autolus Therapeutics, London, UK., Bughda R; Autolus Therapeutics, London, UK., Akbar Z; Autolus Therapeutics, London, UK., Srivastava S; Autolus Therapeutics, London, UK., Gannon I; Autolus Therapeutics, London, UK., Robson M; Autolus Therapeutics, London, UK., Sillibourne J; Autolus Therapeutics, London, UK., Jha R; Autolus Therapeutics, London, UK., El-Kholy M; Autolus Therapeutics, London, UK., Amin OM; Autolus Therapeutics, London, UK., Kokalaki E; Autolus Therapeutics, London, UK., Banani MA; Autolus Therapeutics, London, UK., Hussain R; Autolus Therapeutics, London, UK., Day W; Autolus Therapeutics, London, UK., Lim WC; Autolus Therapeutics, London, UK., Ghongane P; Autolus Therapeutics, London, UK., Hopkins JR; Cardiff University School of Medicine; Heath Park, Cardiff, UK., Jungherz D; Department of Hematology, Cell Therapy, Hemostaseology, and Infectious Diseases, University of Leipzig Medical Centre, Leipzig, Germany., Herling M; Department of Hematology, Cell Therapy, Hemostaseology, and Infectious Diseases, University of Leipzig Medical Centre, Leipzig, Germany., Welin M; Saromics Inc., Lund, Sweden., Surade S; Iontas Ltd., Pampisford, Cambridge, UK., Dyson M; Iontas Ltd., Pampisford, Cambridge, UK., McCafferty J; Iontas Ltd., Pampisford, Cambridge, UK., Logan D; Saromics Inc., Lund, Sweden., Cordoba S; Autolus Therapeutics, London, UK., Thomas S; Autolus Therapeutics, London, UK., Sewell A; Cardiff University School of Medicine; Heath Park, Cardiff, UK., Maciocia P; Cancer Institute; University College London, London, UK., Onuoha S; Autolus Therapeutics, London, UK., Pule M; Autolus Therapeutics, London, UK. m.pule@ucl.ac.uk.; Cancer Institute; University College London, London, UK. m.pule@ucl.ac.uk.
Source: Nature communications [Nat Commun] 2024 Feb 21; Vol. 15 (1), pp. 1583. Date of Electronic Publication: 2024 Feb 21.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2041-1723
DOI:10.1038/s41467-024-45854-3